ORIC Pharmaceuticals Statistics Share Statistics ORIC Pharmaceuticals has 85.22M
shares outstanding. The number of shares has increased by 20.81%
in one year.
Shares Outstanding 85.22M Shares Change (YoY) 20.81% Shares Change (QoQ) 19.99% Owned by Institutions (%) 99.99% Shares Floating 42.35M Failed to Deliver (FTD) Shares 1,461 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 12.29M, so 17.29% of the outstanding
shares have been sold short.
Short Interest 12.29M Short % of Shares Out 17.29% Short % of Float 17.59% Short Ratio (days to cover) 19.52
Valuation Ratios The PE ratio is -4.4 and the forward
PE ratio is -5.31.
ORIC Pharmaceuticals's PEG ratio is
0.66.
PE Ratio -4.4 Forward PE -5.31 PS Ratio 0 Forward PS 95.3 PB Ratio 2.31 P/FCF Ratio -4.94 PEG Ratio 0.66
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ORIC Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.56,
with a Debt / Equity ratio of 0.01.
Current Ratio 10.56 Quick Ratio 10.56 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.05M Employee Count 122 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 10.99% in the
last 52 weeks. The beta is 1.69, so ORIC Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.69 52-Week Price Change 10.99% 50-Day Moving Average 10.15 200-Day Moving Average 8.47 Relative Strength Index (RSI) 35.5 Average Volume (20 Days) 1,367,175
Income Statement
Revenue n/a Gross Profit n/a Operating Income -142.9M Net Income -127.85M EBITDA -126.74M EBIT n/a Earnings Per Share (EPS) -1.83
Full Income Statement Balance Sheet The company has 59.41M in cash and 3.18M in
debt, giving a net cash position of 56.22M.
Cash & Cash Equivalents 59.41M Total Debt 3.18M Net Cash 56.22M Retained Earnings -562.77M Total Assets 242.86M Working Capital 193.82M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -112.66M
and capital expenditures 0, giving a free cash flow of -113.85M.
Operating Cash Flow -112.66M Capital Expenditures n/a Free Cash Flow -113.85M FCF Per Share -1.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
